Education
About Us
Working with TipRanks
Follow Us
SI-Bone Inc (SIBN)
NASDAQ:SIBN
SIBN Stock Chart & Stats
$15.26
$0.02(0.14%)
At close: 4:00 PM EST
$15.26
$0.02(0.14%)
Day’s Range― - ―
52-Week Range$11.70 - $20.05
Previous CloseN/A
Volume50.81K
Average Volume (3M)425.01K
Market Cap
$681.20M
Enterprise Value$696.66M
Total Cash (Recent Filing)$144.41M
Total Debt (Recent Filing)$37.15M
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Nov 10, 2025EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding43,140,938
10 Day Avg. Volume329,836
30 Day Avg. Volume425,007
Financial Highlights & Ratios
PEG Ratio0.56
Price to Book (P/B)3.48
Price to Sales (P/S)3.48
P/FCF Ratio-25.36
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue3.94
Enterprise Value/Gross Profit4.98
Enterprise Value/Ebitda-37.13
Forecast
1Y Price Target
$23.83Price Target Upside56.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Business GrowthSI-BONE management was pleased with their performance and the fact that all three business segments are growing double-digits.
New Product LaunchIn 1Q26, SI-BONE anticipates the launch of a new product targeting the ASC environment, further penetrating the SI-joint space.
Sales PotentialManagement believes hitting half a billion in sales is achievable through continued innovation, strong clinical evidence, improving reimbursement, and further surgeon penetration.
Bears Say
SI-Bone News
SIBN FAQ
What was SI-Bone Inc’s price range in the past 12 months?
SI-Bone Inc lowest stock price was $11.70 and its highest was $20.05 in the past 12 months.
What is SI-Bone Inc’s market cap?
SI-Bone Inc’s market cap is $681.20M.
When is SI-Bone Inc’s upcoming earnings report date?
SI-Bone Inc’s upcoming earnings report date is Nov 10, 2025 which is in 11 days.
How were SI-Bone Inc’s earnings last quarter?
SI-Bone Inc released its earnings results on Aug 04, 2025. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.183 by $0.043.
Is SI-Bone Inc overvalued?
According to Wall Street analysts SI-Bone Inc’s price is currently Undervalued.
Does SI-Bone Inc pay dividends?
SI-Bone Inc does not currently pay dividends.
What is SI-Bone Inc’s EPS estimate?
SI-Bone Inc’s EPS estimate is -0.17.
How many shares outstanding does SI-Bone Inc have?
SI-Bone Inc has 43,140,938 shares outstanding.
What happened to SI-Bone Inc’s price movement after its last earnings report?
SI-Bone Inc reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.183. Following the earnings report the stock price went down -10.615%.
Which hedge fund is a major shareholder of SI-Bone Inc?
Currently, no hedge funds are holding shares in SIBN
SI-Bone Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.83 (56.16% Upside)
$23.83 (56.16% Upside)
Blogger Sentiment
Bullish
SIBN Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 35.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $680.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
28.68%
12-Months-Change
Fundamentals
Return on Equity
-14.18%
Trailing 12-Months
Asset Growth
3.16%
Trailing 12-Months
Company Description
SI-Bone Inc
SI-Bone, Inc. is a medical device company focused on transforming the treatment of sacroiliac joint disorders. The company is primarily engaged in the development and commercialization of innovative surgical implants and technologies designed to provide relief for patients suffering from chronic pain related to these disorders. SI-Bone's core products include the iFuse Implant System, which is utilized in minimally invasive surgical procedures to stabilize the sacroiliac joint, thus alleviating pain and improving functionality for patients. The company operates within the orthopedic and spinal surgery sectors, targeting both hospitals and outpatient facilities.
SIBN Company Deck
SIBN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
SI-BONE's earnings call highlighted strong revenue growth, improved profitability, and successful market expansion, despite some regulatory delays in Europe and continued net losses. The positive performance significantly outweighs the challenges faced.View all SIBN earnings summariesSIBN Stock 12 Month Forecast
Average Price Target
$23.83
▲(56.16% Upside)
Technical Analysis
Ownership Overview
4.97% Insiders
26.91% Mutual Funds
0.87% Other Institutional Investors
56.95% Public Companies and
Individual Investors